|
1
|
Fong AP and Tapscott SJ: Skeletal muscle
programming and re-programming. Curr Opin Genet Dev. 23:568–573.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arndt CA, Rose PS, Folpe AL and Laack NN:
Common musculoskeletal tumors of childhood and adolescence. Mayo
Clin Proc. 87:475–487. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Perez EA, Kassira N, Cheung MC, Koniaris
LG, Neville HL and Sola JE: Rhabdomyosarcoma in children: a SEER
population based study. J Surg Res. 170:e243–e251. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Charytonowicz E, Cordon-Cardo C,
Matushansky I and Ziman M: Alveolar rhabdomyosarcoma: is the cell
of origin a mesenchymal stem cell? Cancer Lett. 279:126–136. 2009.
View Article : Google Scholar
|
|
5
|
Hatley ME, Tang W, Garcia MR, et al: A
mouse model of rhabdomyosarcoma originating from the adipocyte
lineage. Cancer Cell. 22:536–546. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Barr FG: Molecular genetics and
pathogenesis of rhabdomyosarcoma. J Pediatr Hematol Oncol.
19:483–491. 1997. View Article : Google Scholar
|
|
7
|
Novák J, Vinklárek J, Bienertová-Vašků J
and Slabý O: MicroRNAs involved in skeletal muscle development and
their roles in rhabdomyosarcoma pathogenesis. Pediatr Blood Cancer.
60:1739–1746. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang F, Fu XD, Zhou Y and Zhang Y:
Down-regulation of the cyclin E1 oncogene expression by
microRNA-16-1 induces cell cycle arrest in human cancer cells. BMB
Rep. 42:725–730. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang F, Niu G, Chen X and Cao F: Molecular
imaging of microRNAs. Eur J Nucl Med Mol Imaging. 38:1572–1579.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang F, Song X, Li X, et al: Noninvasive
visualization of microRNA-16 in the chemoresistance of gastric
cancer using a dual reporter gene imaging system. PLoS One.
8:e617922013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ciarapica R, Russo G, Verginelli F, et al:
Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma.
Cell Cycle. 8:172–175. 2009. View Article : Google Scholar
|
|
14
|
Davicioni E, Anderson JR, Buckley JD,
Meyer WH and Triche TJ: Gene expression profiling for survival
prediction in pediatric rhabdomyosarcomas: a report from the
children’s oncology group. J Clin Oncol. 28:1240–1246. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gougelet A, Perez J, Pissaloux D, et al:
miRNA profiling: How to bypass the current difficulties in the
diagnosis and treatment of sarcomas. Sarcoma. 2011:4606502011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bentzinger CF, Wang YX and Rudnicki MA:
Building muscle: molecular regulation of myogenesis. Cold Spring
Harb Perspect Biol. 4:a0083422012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Buckingham M: Skeletal muscle formation in
vertebrates. Curr Opin Genet Dev. 11:440–448. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Berkes CA and Tapscott SJ: MyoD and the
transcriptional control of myogenesis. Semin Cell Dev Biol.
16:585–595. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Stockdale FE: Mechanisms of formation of
muscle fiber types. Cell Struct Funct. 22:37–43. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu L, Zhou L, Chen EZ, et al: A novel
YY1-miR-1 regulatory circuit in skeletal myogenesis revealed by
genome-wide prediction of YY1-miRNA network. PLoS One.
7:e275962012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen JF, Mandel EM, Thomson JM, et al: The
role of microRNA-1 and microRNA-133 in skeletal muscle
proliferation and differentiation. Nat Genet. 38:228–233. 2006.
View Article : Google Scholar
|
|
22
|
Kim HK, Lee YS, Sivaprasad U, Malhotra A
and Dutta A: Muscle-specific microRNA miR-206 promotes muscle
differentiation. J Cell Biol. 174:677–687. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dey BK, Gagan J and Dutta A: miR-206 and
-486 induce myoblast differentiation by downregulating Pax7. Mol
Cell Biol. 31:203–214. 2011. View Article : Google Scholar :
|
|
24
|
Huang MB, Xu H, Xie SJ, Zhou H and Qu LH:
Insulin-like growth factor-1 receptor is regulated by microRNA-133
during skeletal myogenesis. PLoS One. 6:e291732011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McCarthy JJ: MicroRNA-206: the skeletal
muscle-specific myomiR. Biochim Biophys Acta. 1779:682–691. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao Y, Samal E and Srivastava D: Serum
response factor regulates a muscle-specific microRNA that targets
Hand2 during cardiogenesis. Nature. 436:214–220. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sweetman D, Goljanek K, Rathjen T, et al:
Specific requirements of MRFs for the expression of muscle specific
microRNAs, miR-1, miR-206 and miR-133. Dev Biol. 321:491–499. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao Y, Ransom JF, Li A, et al:
Dysregulation of cardiogenesis, cardiac conduction and cell cycle
in mice lacking miRNA-1-2. Cell. 129:303–317. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rao PK, Missiaglia E, Shields L, et al:
Distinct roles for miR-1 and miR-133a in the proliferation and
differentiation of rhabdomyosarcoma cells. FASEB J. 24:3427–3437.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Anderson C, Catoe H and Werner R: MIR-206
regulates connexin43 expression during skeletal muscle development.
Nucleic Acids Res. 34:5863–5871. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen JF, Tao Y, Li J, et al: microRNA-1
and microRNA-206 regulate skeletal muscle satellite cell
proliferation and differentiation by repressing Pax7. J Cell Biol.
190:867–879. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rosenberg MI, Georges SA, Asawachaicharn
A, Analau E and Tapscott SJ: MyoD inhibits Fstl1 and Utrn
expression by inducing transcription of miR-206. J Cell Biol.
175:77–85. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Crist CG, Montarras D, Pallafacchina G, et
al: Muscle stem cell behavior is modified by microRNA-27 regulation
of Pax3 expression. Proc Natl Acad Sci USA. 106:13383–13387. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wong CF and Tellam RL: MicroRNA-26a
targets the histone methyltransferase Enhancer of Zeste homolog 2
during myogenesis. J Biol Chem. 283:9836–9843. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Feng Y, Cao JH, Li XY and Zhao SH:
Inhibition of miR-214 expression represses proliferation and
differentiation of C2C12 myoblasts. Cell Biochem Funct. 29:378–383.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu J, Luo XJ, Xiong AW, et al:
MicroRNA-214 promotes myogenic differentiation by facilitating exit
from mitosis via down-regulation of proto-oncogene N-ras. J Biol
Chem. 285:26599–26607. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Naguibneva I, Ameyar-Zazoua M, Polesskaya
A, et al: The microRNA miR-181 targets the homeobox protein Hox-A11
during mammalian myoblast differentiation. Nat Cell Biol.
8:278–284. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Naguibneva I, Polesskaya A, Ameyar-Zazoua
M, et al: Micro-RNAs and muscle differentiation. J Soc Biol.
201:367–376. 2007.in French. View Article : Google Scholar
|
|
39
|
Crippa S, Cassano M, Messina G, et al:
miR669a and miR669q prevent skeletal muscle differentiation in
postnatal cardiac progenitors. J Cell Biol. 193:1197–1212. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Slater O and Shipley J: Clinical relevance
of molecular genetics to paediatric sarcomas. J Clin Pathol.
60:1187–1194. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen JF, Callis TE and Wang DZ: microRNAs
and muscle disorders. J Cell Sci. 122(Pt 1): 13–20. 2009.
View Article : Google Scholar :
|
|
42
|
Taulli R, Bersani F, Foglizzo V, et al:
The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma
growth in xenotransplanted mice by promoting myogenic
differentiation. J Clin Invest. 119:2366–2378. 2009.PubMed/NCBI
|
|
43
|
Yan D, Dong Xda E, Chen X, et al:
MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma
development. J Biol Chem. 284:29596–29604. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li L, Sarver AL, Alamgir S and Subramanian
S: Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3
and CCND2 expression in rhabdomyosarcoma. Lab Invest. 92:571–583.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang H, Garzon R, Sun H, et al:
NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis
and rhabdomyosarcoma. Cancer Cell. 14:369–381. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sarver AL, Li L and Subramanian S:
MicroRNA miR-183 functions as an oncogene by targeting the
transcription factor EGR1 and promoting tumor cell migration.
Cancer Res. 70:9570–9580. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Diao Y, Guo X, Jiang L, et al: miR-203, a
tumor suppressor frequently down-regulated by promoter
hypermethylation in rhabdomyosarcoma. J Biol Chem. 289:529–539.
2014. View Article : Google Scholar :
|
|
48
|
Armeanu-Ebinger S, Herrmann D, Bonin M, et
al: Differential expression of miRNAs in rhabdomyosarcoma and
malignant rhabdoid tumor. Exp Cell Res. 318:2567–2577. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sun MM, Li JF, Guo LL, et al: TGF-beta1
suppression of microRNA-450b-5p expression: a novel mechanism for
blocking myogenic differentiation of rhabdomyosarcoma. Oncogene.
33:2075–2086. 2014. View Article : Google Scholar
|
|
50
|
Goljanek-Whysall K, Sweetman D and
Münsterberg AE: microRNAs in skeletal muscle differentiation and
disease. Clin Sci (Lond). 123:611–625. 2012. View Article : Google Scholar
|
|
51
|
Muthiah M, Park IK and Cho CS:
Nanoparticle-mediated delivery of therapeutic genes: focus on miRNA
therapeutics. Expert Opin Drug Deliv. 10:1259–1273. 2013.
View Article : Google Scholar : PubMed/NCBI
|
